During the last session, BioCardia Inc. (NASDAQ:BCDA)’s traded shares were 1.25 million, with the beta value of the company hitting 1.26. At the end of the trading day, the stock’s price was $3.08, reflecting an intraday gain of 10.39% or $0.29. The 52-week high for the BCDA share is $23.25, that puts it down -654.87 from that peak though still a striking 36.36% gain since the share price plummeted to a 52-week low of $1.96. The company’s market capitalization is $10.78M, and the average intraday trading volume over the past 10 days was 0.29 million shares, and the average trade volume was 817.49K shares over the past three months.
BioCardia Inc. (BCDA) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 1.00. BCDA has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BioCardia Inc. (NASDAQ:BCDA) trade information
BioCardia Inc. (BCDA) registered a 10.39% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 10.39% in intraday trading to $3.08, hitting a weekly high. The stock’s 5-day price performance is 13.24%, and it has moved by -23.00% in 30 days. Based on these gigs, the overall price performance for the year is -45.10%. The short interest in BioCardia Inc. (NASDAQ:BCDA) is 1.83 million shares and it means that shorts have 0.95 day(s) to cover.
BioCardia Inc. (BCDA) estimates and forecasts
Statistics show that BioCardia Inc. has outperformed its competitors in share price, compared to the industry in which it operates. BioCardia Inc. (BCDA) shares have gone down -46.28% during the last six months, with a year-to-date growth rate more than the industry average at 38.67% against 17.20. In the rating firms’ projections, revenue will increase 4.80% compared to the previous financial year.
Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 3k by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 64k and 43k respectively.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 30.13%. While earnings are projected to return 38.67% in 2024.
BCDA Dividends
BioCardia Inc. is due to release its next quarterly earnings in October. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
BioCardia Inc. (NASDAQ:BCDA)’s Major holders
BioCardia Inc. insiders own 18.25% of total outstanding shares while institutional holders control 2.47%, with the float percentage being 3.03%. ADVISOR GROUP HOLDINGS, INC. is the largest shareholder of the company, while 10.0 institutions own stock in it. As of 2024-06-30, the company held over 11189.0 shares (or 0.0445% of all shares), a total value of $3798.0 in shares.
